The Wall Street Journal - This Mysterious Drug Can Erase Addiction 'Virtually Overnight'

As the opioid crisis continues to affect communities across the United States, increasing attention has turned toward ibogaine, a psychoactive compound that some researchers and clinicians are studying for its potential role in interrupting addiction and easing withdrawal symptoms. Because ibogaine remains illegal in the U.S., many individuals seeking treatment travel abroad to clinics in countries where the therapy is permitted.

In this report, The Wall Street Journal visits Ambio Life Sciences in Tijuana, Mexico, documenting one patient’s experience with ibogaine treatment and exploring the broader conversation around its risks, potential benefits, and the growing interest in studying the compound within regulated medical research.